Objective sleep markers of suicidal behaviors in patients with psychiatric disorders: A systematic review and meta-analysis

Romier, Alix; Maruani, Julia; López-Castromán, Jorge; Palagini, Laura; Serafini, Gianluca; Lejoyeux, Michel; d’Ortho, Marie-Pia; Geoffroy, Pierre A.

doi:10.1016/j.smrv.2023.101760

Cited by 17 publications

(7 citation statements)

References 83 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Insomnia, a key symptom of depression diagnosis, also predicted future SA independent of depression severity. The finding that insomnia predicted a suicide attempt was in line with population based study in older adults showing that poor subjective sleep quality increased the risk of death by suicide in longitudinal analyses and two meta-analytic studies showing that in patients with mental disorders both subjective and objective sleep markers like insomnia and decreased total sleep time are associated with an increased risk of STB (Malik et al, 2014;Romier et al, 2023).…”

Section: Integrated Discussion Of Findingssupporting

confidence: 60%

Suicidality in Depression and Anxiety

Eikelenboom

View full text Add to dashboard Cite

show abstract

Section: Integrated Discussion Of Findingssupporting

confidence: 60%

Suicidality in Depression and Anxiety

Eikelenboom

View full text Add to dashboard Cite

show abstract

“…While sleep disturbances, particularly insomnia, are now recognised as independent biological risk factors for suicidal risk (Geoffroy et al, 2021; Romier et al, 2023), very few studies examined the role of sleep disturbances in the peripartum period. Our review identified a total of 13 studies examining this topic, but certain studies such as Sit et al (2015), Weng et al (2016), and Coker et al (2017) were excluded due to their assessment of sleep quality using only a few questions rather than specific questionnaires.…”

Section: Discussionmentioning

confidence: 99%

“…Although sleep disturbances, especially insomnia and reduced total sleep time, are currently considered independent biological risk factors for suicidal risk (Geoffroy et al, 2021; Romier et al, 2023), very few studies have examined the role of sleep disturbances in the peripartum period. To explore this further, we conducted a systematic review and meta‐analysis of data available on the potential association between insomnia, poor sleep quality, and suicidal risk during the peripartum period and discussed the potential neurobiological links.…”

Section: Introductionmentioning

confidence: 99%

Insomnia, poor sleep quality and perinatal suicidal risk: A systematic review and meta‐analysis

Palagini

Cipriani²,

Bramante³

et al. 2023

Journal of Sleep Research

Self Cite

View full text Add to dashboard Cite

SummarySuicidal risk in mothers is a public health priority. Risk factors include biological, psychological and psychosocial factors. Among the biological factors, the role of sleep disturbances as potential contributors to increased suicidal risk during the peripartum period is becoming apparent. To explore this further, we conducted a systematic review following the PRISMA criteria. Currently, 10 studies have examined the role of insomnia and poor sleep quality in suicidal risk during the peripartum period and have involved 807,760 women. The data showed that disturbed sleep and poor sleep quality increase the risk of suicidal ideation in both pregnant women with and without perinatal depression. The results of the meta‐analysis indicated that insomnia and poor sleep quality increase the odds of suicidal risk in pregnant women by more than threefold (OR = 3.47; 95% CI: 2.63–4.57). Specifically, the odds ratio (OR) for poor sleep quality was 3.72 (95% CI: 2.58–5.34; p < 0.001), and for insomnia symptoms, after taking into account perinatal depression, was 4.76 (95% CI: 1.83–12.34; p < 0.001). These findings emphasise the importance of assessing and addressing sleep disturbances during the peripartum period to mitigate their adverse effects on peripartum psychopathology and suicidal risk.

show abstract

“…Grandner and Fernandez compared our need for sleep with that for air, food and water 1. Impairment in sleep can cause a decrease in the quality of life and contribute to cardiovascular, metabolic, neurological and psychiatric disorders 2–8. Conversely, the American Heart Association recently added sleep as one of the essential factors in cardiovascular health (Life’s Essential 8) 8 9…”

Section: Introductionmentioning

confidence: 99%

Drug therapies for obstructive sleep apnoea: a systematic review and meta-analysis protocol

Nobre,

Sarmento,

Medeiros

et al. 2024

BMJ Open

View full text Add to dashboard Cite

IntroductionObstructive sleep apnoea (OSA) is a common disorder that can affect the quality of life and increase the risk for psychiatric, neurological and cardiometabolic diseases. Despite the significant burden, it poses on health and well-being, there is a lack of evidence regarding the use of drug therapies in these patients. This work aims to evaluate the efficacy and safety of pharmacological treatment alternatives for patients with OSA.Methods and analysisDatabases, including PubMed, Embase, Web of Science, SciELO, LILACS, Scopus, Cochrane Register of Controlled Trials and ClinicalTrials.gov, will be used for the search. A search strategy was developed to retrieve clinical trials that have evaluated polysomnographic primary outcome (Apnoea-Hypopnoea index) and secondary outcomes (eg, daytime sleepiness, adverse events) of any drug therapy used for OSA. No date or language restrictions will be applied. Two authors will independently select the studies meeting the inclusion criteria by screening the title, abstract and full text. Data will be extracted, and the risk of bias will be evaluated using the Cochrane Risk of Bias Tool. Review Manager V.5.4.1 will be used for data synthesis. The Grading of Recommendation Assessment, Development and Evaluation will be used to assess the strength of the evidence.Ethics and disseminationAs a review of published data, it is not necessary to obtain ethical approval. The findings of this systematic review will be published in a peer-reviewed journal.PROSPERO registration numberCRD42022362639.

show abstract

Objective sleep markers of suicidal behaviors in patients with psychiatric disorders: A systematic review and meta-analysis

Cited by 17 publications

References 83 publications

Suicidality in Depression and Anxiety

Suicidality in Depression and Anxiety

Insomnia, poor sleep quality and perinatal suicidal risk: A systematic review and meta‐analysis

Drug therapies for obstructive sleep apnoea: a systematic review and meta-analysis protocol

Contact Info

Product

Resources

About